Pulmonary hypertension (PH) comprises five groups of serious clinical entities characterized
by pulmonary artery vasoconstriction and vascular remodeling leading to right heart failure …

Idiopathic pulmonary arterial hypertension (IPAH) is a rapidly progressive disease with
several treatment options. Long-term mortality remains high with great heterogeneity in …

Our understanding of, and approach to, pulmonary arterial hypertension has undergone a
paradigm shift in the past decade. Once a condition thought to be dominated by increased …

Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

Recent investigations have suggested that it might be possible to reverse the pathology of
pulmonary arterial hypertension (PAH), a disorder that can be rapidly progressive and fatal …

WHO classification that is intended to group diseases with similar pathologic,
pathophysiologic, clinical, and therapeutic features. The second category—pulmonary …

Pulmonary arterial hypertension (PAH) is a vascular remodeling disease with a relentless
course toward heart failure and early death. Existing PAH therapies, all of which were …

Pulmonary arterial hypertension (PAH) is an uncommon, progressive and life threatening
disease characterized by a proliferative vasculopathy of the small muscular pulmonary …

The 3rd World Symposium on Pulmonary Arterial Hypertension has been a forum for the
presentation and discussion of overviews on several aspects of this devastating disease …

Pulmonary arterial hypertension (PAH) is a disease characterized by progressive loss and
remodeling of the pulmonary arteries, resulting in right heart failure and death. Until recently …